Safety and Efficacy of Cryoablation for Metastatic Lung Tumors
- First Posted Date
- 2011-03-03
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01307501
- Locations
- 🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Ronald Regan UCLA Medical Center, Los Angeles, California, United States
🇺🇸Mayo Clinic Rochester, Rochester, Minnesota, United States
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry
- First Posted Date
- 2011-02-11
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 394
- Registration Number
- NCT01294449
- Locations
- 🇺🇸
University of Rochester /Strong Memorial, Rochester, New York, United States
SuperNOVA Clinical Stenting Trial
- Conditions
- Interventions
- First Posted Date
- 2011-02-10
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 299
- Registration Number
- NCT01292928
- Locations
- 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇧🇪Universitair Ziekenhuis Gent, Gent, Belgium
🇯🇵Kansai Rosai Hospital, Amagasaki-shi, Hyogo, Japan
Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
- Conditions
- Interventions
- First Posted Date
- 2011-01-31
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT01285999
- Locations
- 🇨🇳
Cardiovascular Institute and Fu Wai Hospital, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, China
🇨🇳Shanghai 6th People's Hospital, Jiaotong University, Shanghai, China
Restoration of Atrioventricular Synchrony Trial
- Conditions
- Interventions
- First Posted Date
- 2011-01-12
- Last Posted Date
- 2017-06-26
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 2
- Registration Number
- NCT01275833
The Jetstream G3™ Calcium Study
- Conditions
- Interventions
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 55
- Registration Number
- NCT01273623
- Locations
- 🇺🇸
Arizona Heart Institute, Phoenix, Arizona, United States
🇺🇸St. John Hopital, Detroit, Michigan, United States
🇺🇸Mercy Medical Center, Knoxville, Tennessee, United States
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
- Conditions
- Interventions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2018-03-19
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 302
- Registration Number
- NCT01253200
- Locations
- 🇺🇸
Swedish Medical Center, Seattle, Washington, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Cleveland Clinic Foundation, Cleveland, Ohio, United States
Study of Cytrix Use in Pelvic Floor Prolapse Treatment
- Conditions
- Interventions
- First Posted Date
- 2010-11-19
- Last Posted Date
- 2010-11-19
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 45
- Registration Number
- NCT01244165
TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2017-02-03
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1014
- Registration Number
- NCT01242696
- Locations
- 🇧🇪
Algemeen Ziekenhuis Sint-Jan, Brugge, Belgium
🇧🇪H-Hartziekenhuis Roeselare-Menen vzw, Roeselare, Belgium
🇫🇷CHU Grenoble, Grenoble, France
Evaluation of Left Ventricular Autothreshold, Phase Two
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2012-10-03
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT01242722
- Locations
- 🇺🇸
Regional Cardiovascular Medical Center, Stuebenville, Ohio, United States